Printer Friendly

Cancer hope for arthritis drug.

A CONTROVERSIAL arthritis drug may prevent skin cancer developing in susceptible individuals, research suggests.

Celecoxib reduced the likelihood of pre-cancerous abnormal cells generating non-melanoma skin tumours.

The drug, marketed in the UK under the name Celebrex, is a non-steroidal anti-inflammatory drug (NSAID). It targets the enzyme cyclo-oxygenase 2 which is believed to be involved in the development of nonmelanoma skin cancers triggered by too much sun exposure. Four years ago the drug was at the centre of controversy after research suggested it might increase the risk of heart attacks and strokes.

Celecoxib belongs to the same drug family as Vioxx, withdrawn from the market following similar concerns.
COPYRIGHT 2010 Coventry Newpapers
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Coventry Evening Telegraph (England)
Geographic Code:4EUUK
Date:Nov 30, 2010
Words:107
Previous Article:SCHOOLS PROTEST OVER SPORTS CUTS.
Next Article:COMMUNITY ORDER FOR BIRD TRAPPER.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters